Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2507
https://www.valueinhealthjournal.com/article/S1098-3015(14)04437-4/fulltext
Title : Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04437-4&doi=10.1016/j.jval.2014.08.2507
First page : A675
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1958
Categories :
Tags :
Regions :
ViH Article Tags :